How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

702 results for

Dysuria in Children

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

561. How to create a modern superhero

How to create a modern superhero How to create a modern superhero How to create a modern superhero | | September 23, 2016 168 Shares You start out by working in a busy emergency department. You see patients with all sorts of complaints: abdominal pain, headaches, and chest pain. Vomiting, diarrhea, and dysuria. Ankle sprains, bug bites, and allergic reactions. Domestic violence, rape, and child abuse. You don’t ever let the stress of the job take away your humanity. You treat your patients (...) have him treat abused patients during the day, and then go after the psychopaths who hurt them at night: the wife beaters, rapists, and child molesters. You make him cunning enough to be able to gather information during his shift, and use that information at night to target the psychopaths. You add depth to this character, place him in a city where you used to work, and add a love story. Soon you realize that one page has led to two hundred. You send it to friends for review, find a professional

2016 KevinMD blog

562. Postrenal Failure

Postrenal Failure Postrenal Failure Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Postrenal Failure Postrenal Failure Aka: Postrenal (...) that results in dilatation of the renal pelvis and calyces. It is caused by obstruction of urine flow, nephrolithiasis, or vesicoureteral reflux. Signs and symptoms include flank pain, nausea, vomiting, fever, and dysuria. Definition (NCI_NCI-GLOSS) Abnormal enlargement of a kidney, which may be caused by blockage of the ureter (such as by a kidney stone) or chronic kidney disease that prevents urine from draining into the bladder. Definition (CSP) distention of the pelvis and calices of the kidney

2015 FP Notebook

563. Vulvar Lichen Sclerosus

Vulvar Lichen Sclerosus Vulvar Lichen Sclerosus Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Vulvar Lichen Sclerosus Vulvar Lichen (...) subepithelial fibrosis. Clinical manifestations include pruritus, dysuria, and dyspareunia. Definition (MSH) Atrophy and shriveling of the SKIN of the VULVA that is characterized by the whitish LICHEN SCLEROSUS appearance, inflammation, and PRURITUS. Concepts Disease or Syndrome ( T047 ) MSH ICD10 SnomedCT 73057003 , 156019006 , 198379009 , 266666006 , 26348009 , 198380007 English Vulvae, Kraurosis , Leukoplakic vulvitis , VULVAL LEUKOPLAKIA , kraurosis of vulva (diagnosis) , kraurosis of vulva

2015 FP Notebook

564. Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)

is based on 24 hour periods from the first dose date and time. ] Number of patients with symptomatic resolution (or return to premorbid state) of UTI-specific symptoms except flank pain (frequency/urgency/dysuria/suprapubic pain) with resolution of or improvement in flank pain based on the patient-reported symptom assessment response at the Day 5 visit in the mMITT analysis set. The sponsor will conclude noninferiority if the lower limit of the 95% CI of difference (corresponding to a 97.5% 1-sided (...) ) of all UTI-specific symptoms (frequency/urgency/dysuria/suprapubic pain/flank pain) based on the patient-reported symptom assessment response at the TOC visit in the mMITT analysis set. The sponsor will conclude noninferiority if the lower limit of the 95% CI of difference (corresponding to a 97.5% 1-sided lower bound) is greater than -12.5% for both FDA coprimary outcome variables (symptomatic resolution at day 5 or favorable combined response at test of cure (TOC)). Per-patient Microbiological

2012 Clinical Trials

565. Safety and Efficacy of Therapeutic INduced HYPERTENSION in Acute Non-cardioembolic Ischemic Stroke (SETIN-HYPERTENSION)

of the clinical deterioration) Myocardial infarction death from any cause Minor safety outcome [ Time Frame: From date of randomization until the date of first documented intracranial hemorrhage on follow-up MRI, or date of first documented side effects, whichever came first, assessed up to 3 months ] Intracranial hemorrhage on follow-up MRI Side effects including headache, arrhythmia, chest pain, dysuria, or gastrointestinal hemorrhage Eligibility Criteria Go to Information from the National Library (...) of Medicine Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Layout table for eligibility information Ages Eligible for Study: Child, Adult, Older Adult Sexes Eligible for Study: All Accepts Healthy Volunteers: No Criteria Inclusion Criteria: Patients

2012 Clinical Trials

566. Botulinum Toxin Urethral Sphincter Injection for Dysfunctional Voiding

: Adults with age of 20 years old or above. Free of active urinary tract infection. Free of bladder outlet obstruction on enrollment. Patients should have severe dysuria or urinary retention, large residual urine and have been treated with medication or other therapeutic modality for over 3 months. Exclusion Criteria: Patients with severe cardiopulmonary disease and such as congestive heart failure, arrhythmia, poorly controlled hypertension, not able to receive regular follow-up. Patients with bladder (...) is pregnant, lactating, or with child-bearing potential without contraception. Patients with any other serious disease considered by the investigator not suitable for general anesthesia or in the condition to enter the trial. Patients participated investigational drug trial within 1 month before entering this study. Written informed consent has been obtained. Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact

2012 Clinical Trials

567. Efficacy of Extracorporal Shock Wave Therapy in Patient With Chronic Non-bacterial Prostatitis / Chronic Pelvic Pain Syndrome

could be due to endometrioses, ovarian cyst, colitis, etc, making the correct diagnosis important (1-3). The most prevalent reason for CPP in men is non-bacterial chronic prostatitis and in many cases they are considered equivalent to each other (4). Chronic non-bacterial prostatitis is associated with pain in pelvic region and could be associated with other symptoms such as dysuria, myalgia, arthralgia, chronic fatigue, burning sensation in the urethra, abdominal, urine frequency, and pain after (...) Layout table for investigator information Principal Investigator: Farshid Alizadeh, pediatric urologist Isfahan University of Medical Sciense More Information Go to Layout table for additonal information Responsible Party: Farshid Alizadeh, pediatric urologist, Isfahan University of Medical Sciences ClinicalTrials.gov Identifier: Other Study ID Numbers: IsfahanUMS1 First Posted: October 26, 2012 Last Update Posted: October 26, 2012 Last Verified: October 2012 Additional relevant MeSH terms: Layout

2012 Clinical Trials

568. Characterization of the Effects of Prolonged-release Fampridine on Ambulatory Function in Patients With Multiple Sclerosis

in childhood. Any prior treatment with anti-epileptic medications specifically prescribed for the treatment of epilepsy. Onset of MS exacerbation within the 60 days prior to the Screening Visit. Use of mitoxantrone, cyclophosphamide, rituximab, alemtuzumab, daclizumab, cladribine or any other immune suppressant (except FTY720) or antibody (except natalizumab) within 3 months prior to the Screening Visit, or scheduled use during study participation. Pulsed steroid treatment within the 60 days prior (...) of drugs under study, e.g. known allergy to pyridine-containing substances. Any prior treatment with fampridine (4-aminopyridine; 4 AP) or 3,4-diaminopyridine in any formulation. Patients with an acute urinary tract infection at the Screening Visit as indicated by symptoms like painful urination/dysuria, urinary frequency, urinary urgency, pollakiuria, suprapubic pain, flank pain, costovertebral angle tenderness or fever >38°C in combination with a clinically significant pathological finding

2012 Clinical Trials

569. Compare Ceftazidime-Avibactam and Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)

is based on 24 hour periods from the first dose date and time. ] Number of patients with symptomatic resolution (or return to premorbid state) of UTI-specific symptoms except flank pain (frequency/urgency/dysuria/suprapubic pain) with resolution of or improvement in flank pain based on the patient-reported symptom assessment response at the Day 5 visit in the mMITT analysis set. The sponsor will conclude noninferiority if the lower limit of the 95% CI of difference (corresponding to a 97.5% 1-sided (...) ) of all UTI-specific symptoms (frequency/urgency/dysuria/suprapubic pain/flank pain) based on the patient-reported symptom assessment response at the TOC visit in the mMITT analysis set. The sponsor will conclude noninferiority if the lower limit of the 95% CI of difference (corresponding to a 97.5% 1-sided lower bound) is greater than -12.5% for both FDA coprimary outcome variables (symptomatic resolution at day 5 or favorable combined response at test of cure (TOC)). Per-patient Microbiological

2012 Clinical Trials

570. Symptom profile variability of interstitial cystitis/painful bladder syndrome by age. (Abstract)

specific investigation into the symptoms they experience. We identified that patients diagnosed with interstitial cystitis and painful bladder syndrome have variable clinical symptom profiles depending on the age at the time of their diagnosis. Dyspareunia, external genitalia pain, urgency, frequency and dysuria were more common in younger patients whereas nocturia, urinary incontinence and the presence of Hunner's ulcers were more common in older patients. Better defining symptom profiles for patients (...) at the time of evaluation may potentially aid in more accurate and expedited diagnosis of these conditions, particularly in the youngest patient population which is being recognized more commonly in recent times.• To investigate the clinical profile differences among patients with interstitial cystitis/painful bladder syndrome (IC/PBS) based upon age at the time of diagnosis from childhood into the geriatric age group.• An analysis of 268 patients with IC/PBS seen between 1990 and 2008 was performed

2012 BJU international

571. Inflammatory Myofibroblastic Tumor of the Bladder in a 10-Year-old Girl. (Abstract)

Inflammatory Myofibroblastic Tumor of the Bladder in a 10-Year-old Girl. Inflammatory myofibroblastic tumors (IMTs) of the bladder are rarely encountered bladder tumors during the pediatric age. The unknown malignant potential of these tumors causes controversy for their treatment and follow-up. We report a 10-year-old girl who was referred to our clinic with dysuria and enuresis. The clinicopathological evaluation was compatible with IMT and a bladder preserving approach was used

2012 Urology

572. Posterior urethral valves diagnosed by bedside ultrasound in the ED. (Abstract)

Posterior urethral valves diagnosed by bedside ultrasound in the ED. Posterior urethral valves are the most common cause of urinary obstruction in male children. Presentations of posterior urethral valves beyond the neonatal period include urinary tract infection, abdominal mass, renal failure,diminished urinary stream, crying during micturition,incontinence, dysuria, hematuria, or failure to thrive. Early diagnosis is imperative because early surgical relief of the obstruction is believed (...) to help prevent the progression to endstage renal disease.This case serves to remind us that, in the male child who presents with urinary symptoms and/or abdominal symptoms,the bedside sonogram is a valuable tool that can clarify the diagnosis and expedite care.

2012 American Journal of Emergency Medicine

573. Efficacy and Safety Of Spil's Estradiol Vaginal Tablet

. Drug: Estradiol one tablet will be inserted daily for 14 days Other Name: Vagifem Outcome Measures Go to Primary Outcome Measures : Vaginal pH [ Time Frame: 14 days ] Secondary Outcome Measures : Symptoms of vulvar and vaginal atrophy [ Time Frame: 14 days ] Each subject will specify identified most bothersome symptoms vaginal dryness, vaginal and/or vulvar irritation/ itching, dysuria, vaginal pain associated with sexual activity, vaginal bleeding associated with sexual activity) and self-evaluate (...) the symptom on a pre-defined scale Eligibility Criteria Go to Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Layout table for eligibility information Ages Eligible for Study: Child, Adult, Older Adult

2012 Clinical Trials

574. Kidney Stones 01: Presentation

Kidney Stones 01: Presentation Kidney Stones 01: Presentation – PEMBlog Search for: Search for: Kidney Stones 01: Presentation This is part of the four part PEMBlog series on kidney stones. Throughout you’ll learn about diagnosis and management of an increasingly recognized problem in the Pediatric Emergency Department. History Family history is suggestive in about 1/7 children with stones. Metabolic disorders (intestinal malabsorption) are risk factors. In children with metabolic disorders (...) likely to be seen upon presentation in adolescents than school-aged children ( ). Ureteral stones are more painful, as the spasm is intense, and older children and adolescents have them two thirds of the time. Hematuria Gross hematuria is less frequent than the microscopic version in one-third to one-half of patients. Note that some voids may be bloody, others not for the individual patient. noted that the absence of gross hematuria had a 100% NPV – but it was only 24 patients. Dysuria Only one

2015 PEM Blog

575. What’s the diagnosis and what’s the gold standard for POCUS??

What’s the diagnosis and what’s the gold standard for POCUS?? What’s the diagnosis and what’s the gold standard for POCUS?? : EDE Blog • March 2, 2015 • A man in his late 50s presented to an ED a while back during the summers months with a 3 day H/O multiple complaints including rhinorhea, sore throat, dry cough, vomiting, loose stool, right frontal headaches, dyspnea, dysuria, and dark urine. So, a mixed picture. Fever of 100.9 was measured at home. No contacts or travel. Pretty healthy (...) standard if done 2 days later or the elective test is not done with a keen eye to look for the findings we’re interested in. Leave a Reply Name ( required ) Email ( required; will not be published ) Website « » Recent Posts April 1st, 2019 I don't have many heroes. Most of mine were accumulated in childhood, a time when that designation p March 25th, 2019 We've talked about this before, but it's time for a reminder. POCUS improves the speed and success March 18th, 2019 Here is another case from Dr

2015 EDE Blog

576. Safety of Probiotics to Reduce Risk and Prevent or Treat Disease

use RCTs 76 Figure 22. RR Number of Children With Adverse Events 82 Figure 23. RR Number of Adults With Adverse Events 83 Figure 24. RR Number of Elderly Participants With Adverse Events 85 Figure 25. RR Number of Critically Ill or High-Risk Participants With Adverse Events 88 Figure 26. Number of Participants With Serious Adverse Events 94 Appendixes Appendix A. Exact Search Strings and List of Manufacturers Appendix B. Sample Data Abstraction Forms Appendix C. Evidence Tables Appendix D (...) no evidence that a particular mechanism or route of administration of probiotic organisms was associated with an increased risk of an adverse event in intervention participants relative to control group participants. Stratified analyses and meta-regressions showed no increased risk of adverse events for children (RR 0.96; 95% CI: 0.88, 1.04; p=0.296, 35 RCTs), adults (RR 0.97; 95% CI: 0.79, 1.19; p=0.745, 40 RCTs), or elderly (RR 0.94; 95% CI: 0.82, 1.08; p=0.367, 4 RCTs) participants compared

2011 EvidenceUpdates

577. Autosomal Dominant Polycystic Kidney Disease (ADPKD)

are not yet sufficient to confirm a favorable benefit/harm balance. In children with autosomal dominant polycystic kidney disease, early use of pravastatin may slow the progression of structural kidney disease . Treatment reference Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 9(5):889-896, 2014. Key Points Autosomal dominant polycystic kidney disease occurs in about 1/1000 (...) , but penetrance is essentially complete; all patients ≥ 80 yr have some signs. In contrast, is rare; incidence is 1/10,000. It frequently causes renal failure during childhood. In 86 to 96% of cases, ADPKD is caused by mutations in the PKD1 gene on chromosome 16, which codes for the protein polycystin 1; most other cases are caused by mutations in the PKD2 gene on chromosome 4, which codes for polycystin 2. A few familial cases are unrelated to either locus. Pathophysiology Polycystin 1 may regulate tubular

2013 Merck Manual (19th Edition)

578. Urinary Frequency

Clinical evaluation Urgency, dysuria, nocturia, purulent urethral discharge with fever, chills, low back pain, myalgia, arthralgia, and perineal fullness Prostate tender to palpation Rectal examination Culture of secretions after prostatic massage Radiation cystitis History of radiation therapy of the lower abdomen, prostate, or perineum for treatment of cancer Clinical evaluation and Asymmetric arthritis of knees, ankles, and metatarsophalangeal joints Unilateral or bilateral conjunctivitis Small (...) Ultrasonography or CT of the kidneys, ureters, and bladder and foul-smelling urine, sometimes fever, confusion, and flank pain, particularly in women and girls Dysuria and frequency in young sexually active men (which suggests an STD) Urinalysis and culture STD testing Bladder detrusor overactivity Nocturia, urge incontinence, weak urinary stream, and sometimes urinary retention Cystometry STD = sexually transmitted disease. Evaluation History History of present illness should first ask about the amounts

2013 Merck Manual (19th Edition)

579. Scrotal Pain

in older men with diabetes, peripheral vascular disease, or both Clinical evaluation Evaluation Expeditious evaluation, diagnosis, and treatment are required because untreated may cause loss of a testis. History History of present illness should determine location (unilateral or bilateral), onset (acute or subacute), and duration of pain. Important associated symptoms include fever, dysuria, penile discharge, and presence of scrotal mass. Patients should be asked about preceding events, including (...) with positive urinalysis, discharge, or dysuria) Color Doppler ultrasonography to rule out torsion (no clear-cut alternate cause) Other testing as suggested by findings (see Table: ) Urinalysis and culture are always required. Findings of UTI (eg, pyuria, bacteriuria) suggest epididymitis. Patients with findings that suggest UTI and patients with urethral discharge or should be tested for STDs as well as other bacterial causes of UTI. Timely diagnosis of testicular torsion is critical. If findings

2013 Merck Manual (19th Edition)

580. Isolated Hematuria

and ureters, prostate, bladder, and urethra. Etiology Most cases involve transient microscopic hematuria that is self-limited and idiopathic. Transient microscopic hematuria is particularly common in children, present in up to 5% of their urine samples. There are numerous specific causes (see Table: ). The most common specific causes differ somewhat by age, but overall the most common are (in adults) Vigorous exercise may cause transient hematuria. Cancer and prostate disease are a concern mainly (...) in patients > 50, although younger patients with risk factors may develop cancer. Glomerular disorders can be a cause at all ages. may represent a primary renal disorder (acquired or hereditary) or be secondary to many causes, including infections (eg, group A beta-hemolytic streptococcal infection), connective tissue disorders and (eg, at all ages, [Henoch-Schönlein purpura] in children), and blood disorders (eg, mixed cryoglobulinemia, serum sickness). Worldwide, is the most common form

2013 Merck Manual (19th Edition)

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>